GVHD - Graft-Versus-Host Disease
Immunology·MeSH: Graft vs Host Disease
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| remestemcel-l-rknd | Mesoblast Limited (MESO) |
Frequently asked questions
How many drugs are in development for GVHD - Graft-Versus-Host Disease?
BioSniper tracks 1 drug in development for GVHD - Graft-Versus-Host Disease across 1 company.
How many clinical trials target GVHD - Graft-Versus-Host Disease?
There are 1 clinical trial targeting GVHD - Graft-Versus-Host Disease tracked by BioSniper.
Deep-dive into GVHD - Graft-Versus-Host Disease
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis